Copyright
©©The Author(s) 2022.
World J Stem Cells. Jan 26, 2022; 14(1): 54-75
Published online Jan 26, 2022. doi: 10.4252/wjsc.v14.i1.54
Published online Jan 26, 2022. doi: 10.4252/wjsc.v14.i1.54
Clinical trial ID | Source of MSC | Diagnosis | Trial phase | Route of administration | Cell product name (modifying factor) | Status |
NCT03298763 | Umbilical cord MSC (not specified) | Adenocarcinoma of lung | I/II | Intravenous | MSCTRAIL (TRAIL) | Recruiting |
NCT02530047 | Bone marrow MSC (not specified) | Ovarian cancer | I | Intraperitoneal | MSC-INFβ (INF-β) | Completed |
NCT02068794 | ASC (not specified) | Ovarian, primary peritoneal or fallopian tube cancer | I/II | Intraperitoneal | (MV-NIS) | Recruiting |
NCT02079324 | Not specified (not specified) | Head and neck cancer | I | Intratumoral | GX-051 (IL-12) | Unknown |
NCT04657315 | Not specified (not specified) | Recurrent glioblastoma | I/II | Intratumoral | MSC11FCD (CD) | Not yet recruiting |
NCT01983709 | Bone marrow MSC (allogenic) | Prostate cancer | I | Intravenous | Not modified | Terminated |
NCT02008539 | Bone marrow MSC (autologous) | Advanced gastrointestinal cancer | I/II | Infusion | MSC_apceth_101 (HSV-TK) | Terminated |
2015-000520-29 | Bone marrow MSC (allogenic) | Advanced gastrointestinal adenocarcinoma | I/II | Intravenous | MSC_apceth_111 | Prematurely ended |
NCT01844661 | Bone marrow MSC (autologous) | Metastatic and refractory solid tumors | I/II | Intravenous | CELYVIR (ICOVIR5) | Completed |
2019-001154-26 | Bone marrow MSC (allogenic) | Relapsed or refractory extracranial solid tumors | I | Intravenous | AloCELYVIR (ICOVIR-5) | Recruiting |
NCT04758533 | Bone marrow MSC (allogenic) | Diffuse intrinsic pontine glioma or medulloblastoma | I/II | Infusion | AloCELYVIR (ICOVIR-5) | Not yet recruiting |
- Citation: Vicinanza C, Lombardi E, Da Ros F, Marangon M, Durante C, Mazzucato M, Agostini F. Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications. World J Stem Cells 2022; 14(1): 54-75
- URL: https://www.wjgnet.com/1948-0210/full/v14/i1/54.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v14.i1.54